Pan-European patent court delivers first revocation judgment a year and a month after opening | 1w
Pan-European patent court delivers first revocation judgment a year and a month after opening | 1w
Any regulatory changes to drug patents and pricing should be wary of stifling innovation, writes Neal Gerber Eisenberg lawyer Thomas Campbell | 1w
Trio of partners join from Wilson Sonsini and boutique Hooper Lundy & Bookman as Orrick continues life sciences push | 2w
Glucose monitoring patent revoked across 17 UPC member states in ongoing dispute with rival Abbott | 2w
This first edition, written by leading AI legal specialists, provides answers and insight on how to integrate Artificial Intelligence into business operations, whilst working within the relevant law and guidelines in key jurisdictions around the world. | 1yr
Editor:
Mathys & Squire patent litigator Stephen Garner discusses changes to EU pharmaceutical legislation and the impact on IP rights | 2w
Freshfields, Taylor Wessing and Powell Gilbert advise on closely watched London High Court dispute | 3w
Swedish companies are imposing age restrictions on their beauty products. Bird & Bird lawyers Caroline Grotenfelt, Julia Jansson and Beatrice Rälg ask if more countries will follow suit? | 1mo
Team moves over from Lerner David strengthening medical device practice | 1mo
Decision upholds earlier ruling revoking patent covering the drug Xarelto, further clearing way for generic manufacturers to enter the lucrative market | 1mo
Led by respected life sciences litigator Siegmund Gutman, the team of 10 move over from Proskauer Rose | 2mos
Düsseldorf local division orders US life sciences company Curio Bioscience to stop selling its products in Germany, France and Sweden in dispute with rival 10x Genomics | 2mos
UK pharmaceutical firm enters the fray in the battle over mRNA technology used to develop blockbuster vaccines | 2mos
Irena Royzman is fourth IP partner to join tech-focused firm this year | 3mos
Bakers’ South Africa M&A co-head Angela Simpson moves over alongside three more lawyers | 3mos
Tech-focused firm sees PEP grow 8.2% following almost 20% decline in 2022 | 4mos
The top 25 US firm secures highly respected team of tech-focused IP litigators in Silicon Valley and Washington DC | 4mos
David Edwards to co-lead European disputes practice alongside Tyler Robinson | 5mos
Kimberly Branscome joins having counselled GSK, 3M and Johnson & Johnson in high-profile litigation | 5mos
Case alleging secret client referral fees can proceed in first appellate ruling on representative actions since Lloyd v Google | 6mos
UK firm hails 'transformational step' in US growth strategy as rainmaker George Casey joins as global co-chair of corporate alongside five more lawyers | 6mos